보고서 요약(국문)

개요
전 세계 커버드 스텐트 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
커버드 스텐트는 금속 스텐트와 마찬가지로 확장 가능하지만, 내부를 직물로 코팅하여 튜브 형태로 만든 혈관 스텐트의 일종입니다. 커버드 스텐트는 혈관 내 동맥류 복원술과 같은 혈관 내 수술에 사용됩니다. 커버드 스텐트는 금속 스텐트를 폴리테트라플루오로에틸렌(PTFE)과 같은 직물 또는 이식재로 코팅한 구조로 이루어져 있습니다. 말초동맥질환 관리에 다양한 임상적 적용 분야를 가지고 있습니다.
적용 분야에는 죽상경화증 치료, 의인성 혈관 천공 또는 파열 봉합, 동맥류 및 가성동맥류 차단, 동정맥루 치료, 기능 부전 투석 이식편 관리 등이 있습니다. 피복 스텐트는 선천성 심장 질환 시술 중 협착되거나 손상된 혈관을 치료하거나 원치 않는 혈관 연결을 차단하는 데 사용됩니다.
또한 피복 스텐트는 관상동맥의 혈전 병변에도 사용되었습니다. 피복 스텐트는 혈관 천공 시 효과적인 구제 전략을 제공하고, 관상동맥류 차단을 위한 수술의 대안이며, 색전증 발생 가능성이 높은 플라크 치료에도 잠재적인 역할을 합니다.
시장 동향: 동인 및 제약 요인
관상동맥 질환 유병률 증가
피복 스텐트는 주로 생명을 위협할 수 있는 관상동맥 천공 및 관상동맥류 치료에 사용되어 왔습니다. 이전 연구에 따르면 스텐트 삽입술은 합병증 없는 생존율을 향상시켜 생명을 위협하는 상황을 응급 수술 없이 관리할 수 있게 하고 사망률, 심장압전, 주요 심장 질환 발생률을 크게 낮추는 것으로 나타났습니다.
관상동맥 질환은 심장에 혈액을 공급하는 동맥(관상동맥) 벽에 플라크가 쌓여 발생합니다. 플라크는 콜레스테롤 침전물로 구성됩니다. 플라크가 쌓이면 시간이 지남에 따라 동맥 내부가 좁아집니다. 이 과정을 죽상경화증이라고 합니다.
예를 들어, 미국 질병통제예방센터(CDC)의 2023년 최신 자료에 따르면 관상동맥 질환은 가장 흔한 심장 질환으로 2021년에 375,476명이 사망했습니다. 20세 이상 성인의 약 1/20(약 5%)이 관상동맥 질환을 앓고 있습니다.2 2021년에는 관상동맥 질환으로 인한 사망자의 약 2/10이 65세 미만 성인이었습니다.

또한, 피복 스텐트의 기술 발전, 고령 인구 증가, 관상동맥 질환 유병률 증가, 스텐트 시술 후 환자 예후 개선 등이 시장 성장에 기여했습니다. 약물 방출 스텐트(DES) 기술의 발전은 기존 플랫폼을 지속적으로 개선하여 스텐트 전달을 향상시키고 생체 적합성이 더 높은 약물 고분자를 개발하는 방향으로 이루어졌습니다.
시장 동향: 제약 요인
피복 스텐트의 가장 흔한 실패 기전은 스텐트 삽입 실패, 스텐트 이탈, 천공 부위 봉합 실패입니다. 삽입 실패는 Graftmaster에서, 스텐트 이탈은 PK Papyrus에서 더 흔하게 나타났습니다. 스텐트 삽입성을 최적화하고 합병증 위험을 최소화하기 위해서는 피복 스텐트 설계의 추가적인 개선이 필요합니다.
또한, 이러한 특수 의료 기기의 높은 비용도 제약 요인입니다. 피복 스텐트는 기존 스텐트보다 가격이 비싼 경우가 많아, 특히 의료 예산이 제한적인 지역에서는 도입이 제한될 수 있습니다. 더욱이, 피복 스텐트 시술에 능숙한 숙련된 중재 심장 전문의의 부족은 시장 성장을 더욱 저해하는 요인입니다.
세그먼트 분석
전 세계 피복 스텐트 시장은 제품 유형, 재질 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
풍선 확장형 혈관 피복 스텐트 부문은 시장 점유율의 약 41.2%를 차지했습니다.
제품 유형 부문에서 풍선 확장형 혈관 피복 스텐트는 41.2%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 풍선 확장형 혈관 피복 스텐트는 총장골동맥 및 외장골동맥의 죽상경화성 병변 치료에 사용됩니다. 풍선 확장형 피복 스텐트는 동맥류 및 협착과 같은 혈관 질환을 치료하기 위해 중재 심장학 및 혈관 외과에서 사용되는 의료 기기입니다. 금속 프레임에 합성 섬유 또는 고분자 재질을 덮어 구성됩니다.

또한, 2022년 9월, 메드트로닉은 자사의 Radiant 풍선 확장형 피복 스텐트에 대해 CE 마크를 획득했다고 발표했습니다. Radiant는 Endurant II/IIs 스텐트 그라프트 시스템과 함께 ChEVAR에 사용하도록 적응증이 있는 최초이자 현재 유일한 피복 스텐트입니다. Endurant II/IIs 스텐트 그라프트와 Radiant 피복 스텐트는 짧은 목을 가진 신장 인접 복부 대동맥류(AAA)에 대한 표준화되고, 적응증에 완전히 부합하는, 즉시 사용 가능한 솔루션을 제공합니다. 이를 통해 임상 결과로 뒷받침되는 검증된 기기 조합으로 응급 및 선택적 신장 인접 AAA 사례 모두에서 안전하고 효과적인 혈관내 치료가 가능합니다.
지리적 분석
유럽은 2022년 시장 점유율의 약 28.4%를 차지했습니다.
유럽은 신제품 출시, 기술 발전, 주요 업체와의 협력, 승인 등 여러 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 28.4%를 유지할 것으로 예상됩니다.
예를 들어, 2022년 9월 게팅(Getinge)은 메드트로닉(Medtronic)과 협력하여 유럽에서 ChEVAR 시술용 Radiant 스텐트를 출시하고 CE 마크를 획득했습니다.
Radiant는 Endurant II/IIs 스텐트 그라프트 시스템을 사용하는 ChEVAR(chimney endovascular aneurysm repair) 시술에 사용하도록 설계된 최초의 피복 스텐트입니다. 스텐트 그라프트와 함께 사용하면 신장 동맥의 혈류 공급을 유지합니다.
또한, 2021년 5월 iVascular는 BX 피복 스텐트 iCover에 대한 CE 마크 승인을 받았습니다. 풍선 확장형(BX) 스텐트는 신장 및 장골 동맥의 동맥경화성 병변 치료와 동맥류 및 파열 치료에 일반적으로 사용됩니다.
COVID-19 영향 분석
COVID-19는 전 세계 스텐트 시장에 상당한 영향을 미쳤습니다. 특히, 새로운 연구 및 자료에 따르면 COVID-19 팬데믹 기간 동안 스텐트 혈전증 발생률이 8.1~21%까지 증가한 것으로 나타났지만, 연구 대상 인구 규모는 상대적으로 작았습니다. COVID-19는 직간접적인 영향으로 심혈관계에 상당한 부담을 주고 있습니다.
COVID-19 팬데믹으로 인한 높은 감염률과 봉쇄 조치로 인해 수술 건수가 감소했습니다. 또한, 심혈관 질환 환자들은 병원 및 진단 시설 방문객 감소로 진단 및 치료가 지연되는 현상을 겪었으며, 이는 스텐트 시장에 부정적인 영향을 미쳤습니다.

경쟁 환경
주요 글로벌 스텐트 시장 업체로는 Becton, Dickinson and Company, B. Braun Interventional Systems Inc., Getinge, Insrtumed Surgical, Inc., Boston Scientific Corporation, Biotronik, Mermaid Medical, Gore Medical, Getz Healthcare, iVascular S.L.U 등이 있습니다.
보고서 구매 이유

• 제품 유형, 재료 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 스텐트 시장 세분화를 시각화하고 주요 기업 및 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.
• 모든 세그먼트를 포함한 스텐트 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품 정보를 담은 Excel 파일 형태의 제품 맵핑을 제공합니다.

• 글로벌 스텐트 시장 보고서는 약 69개의 표, 70개의 그림, 그리고 185페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Covered Stents Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Covered stent is a type of vascular stent with a fabric coating that creates a contained tube but is expandable like a bare metal stent. Covered stents are used in endovascular surgical procedures such as endovascular aneurysm repair. Covered stents are composed of fabric or graft material, such as polytetrafluoroethylene (PTFE), covering a metal stent. They have various clinical applications in peripheral arterial disease management.
Applications include treatment of atherosclerotic disease, sealing iatrogenic vessel perforations or ruptures, exclusion of aneurysms and pseudoaneurysms, treatment of arteriovenous fistulae, and management of failing dialysis grafts. Covered stents are used during congenital cardiac interventions to treat stenotic or injured vessels or to exclude unwanted vascular connections.
Covered stents were also utilised in thrombus-laden lesions in native coronary arteries. Covered stents offer an effective bail-out strategy in vessel perforations, are an alternative to surgery for the exclusion of coronary aneurysms, and have a potential role in the treatment of friable embolisation-prone plaques.
Market Dynamics: Drivers and Restraints
Rise in the prevalence of coronary artery diseases
Covered stents have been mainly used for the treatment of potentially life-threatening coronary artery perforation and coronary artery aneurysms. Prior studies suggest that the use of covered stents improves event-free survival, enabling a life-threatening situation to be managed without emergency surgery and with significantly reduced rates of mortality, cardiac tamponade, and major adverse cardiac events
Coronary artery disease is caused by plaque buildup in the wall of the arteries that supply blood to the heart (called coronary arteries). Plaque is made up of cholesterol deposits. Plaque buildup causes the inside of the arteries to narrow over time. This process is called atherosclerosis
For instance, according to the Centers for Disease Control and Prevention updated factsheet 2023, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. About 1 in 20 adults age 20 and older have CAD (about 5%).2 In 2021, about 2 in 10 deaths from CAD happen in adults less than 65 years old.
Furthermore, technological advancements in covered stents, the rise in the prevalence of the geriatric population, the increase in the prevalence of coronary artery diseases and improvement in patient outcomes with stenting. Advancements in drug-eluting stent (DES) technologies have consisted of continually refining existing platforms to improve stent delivery and develop more biocompatible drug polymers.
Market Dynamics: Restraint
The most common failure mechanisms of covered stents are failure of delivery, stent dislodgement, and failure to seal the perforation. Failure of delivery was more common with Graftmaster, while stent dislodgement was more common with PK Papyrus. Further improvements in covered stent design are needed to optimize deliverability and minimize the risk of complications.
Also, the high cost associated with these specialized medical devices. Covered stents are often more expensive than traditional stents, which can limit their adoption, particularly in regions with constrained healthcare budgets. Moreover, the limited availability of skilled interventional cardiologists proficient in deploying covered stents further hampers the overall market.
Segment Analysis
The global covered stents is segmented based on product type, material type, application, end-user and region.
The balloon expandable vascular-covered stent segment accounted for approximately 41.2% of the market share
The balloon expandable vascular covered stent from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Balloon Expandable Vascular Covered Stent is indicated for the treatment of atherosclerotic lesions in common and external iliac arteries. Balloon-expandable covered stents are medical devices used in interventional cardiology and vascular surgery to treat vascular conditions like aneurysms and stenoses. They consist of a metal framework covered with a synthetic fabric or polymer material.
Moreover, in September 2022, Medtronic set forth that it recently received a CE mark for its Radiant balloon-expandable covered stent, the first and currently only covered stent indicated for use in ChEVAR with the Endurant II/IIs stent graft system. The Endurant II/IIs stent graft and Radiant covered stent offer a standardized, fully on-label, off-the-shelf solution for short-neck, juxtarenal abdominal aortic aneurysms (AAA). This enables safe and effective endovascular repair in both urgent and elective juxtarenal AAA cases, with a proven device combination, backed by clinical outcomes.
Geographical Analysis
Europe accounted for approximately 28.4% of the market share in 2022
Europe is estimated to hold about 28.4% of the total market share throughout the forecast period, owing to the novel product launches, technological advancements, collaboration with the key players, approvals and others that will drive this region further during the forecast period.
For instance, in September 2022, Getinge joined forces with Medtronic to launch a Radiant stent for ChEVAR procedures in Europe which received a CE mark.
Radiant, is the first covered stent which is designed for use in chimney endovascular aneurysm repair (ChEVAR) with the Endurant II/IIs stent graft system. It maintains perfusion to renal arteries when used in combination with the stent graft
Furthermore, in May 2021, iVascular has recently received CE mark approval for its BX-covered stent iCover. Balloon-expanding (BX) covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries and for the treatment of aneurysms and ruptures.
COVID-19 Impact Analysis
Covid 19 had a substantial impact on the global covered stents market importantly, new studies and registers shows that the percentage of stent thrombosis increased during the COVID-19 pandemic, even up to 8.1–21%, however, the study populations were relatively low. COVID-19, due to direct and indirect effects, creates a significant burden on the cardiovascular system.
Due to the high infection rate and lockdown regulations brought on by the COVID-19 pandemic, surgical procedures have been affected. Additionally, patients with cardiovascular diseases have experienced delays in diagnosis and treatment as a result of fewer people visiting hospitals and diagnostic facilities, which has affected the covered stent market.
Competitive Landscape
The major global players in the covered stents market include Becton, Dickinson and Company, B. Braun Interventional Systems Inc., Getinge, Insrtumed Surgical, Inc., Boston Scientific Corporation, Biotronik, Mermaid Medical, Gore Medical, Getz Healthcare, iVascular S.L.U and among others.
Why Purchase the Report?
• To visualize the global covered stents market segmentation-based product type, material type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of covered stents market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global covered stents market report would provide approximately 69 tables, 70 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Rise in the prevalence of coronary artery diseases
4.1.1.2. Rise in the technology advancements
4.1.2. Restraints
4.1.2.1. Side Effects of Toxoid Vaccine
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Balloon Expandable Covered Stents *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bare Metal Covered Stents
7.4. Drug-Eluting Covered Stents
7.5. Bioabsorbable Covered Stents
8. By Material Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.1.2. Market Attractiveness Index, By Material Type
8.2. ePTFE (Expanded Polytetrafluoroethylene) Covered Stents*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Polyester Covered Stents
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Peripheral Vascular Aneurysms *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Coarctation of the Aorta
9.4. Atherosclerotic Diseases
9.5. Coronary Artery Perforations
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers (ASCs)
11. Cardiac Specialty Clinics
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. UK
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. Brazil
12.4.6.2. Argentina
12.4.6.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. Australia
12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Becton, Dickinson and Company
14.1.1. Company Overview
14.1.2. Product Type Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. B. Braun Interventional Systems Inc
14.3. Getinge
14.4. Insrtumed Surgical, Inc
14.5. Boston Scientific Corporation
14.6. Biotronik
14.7. Mermaid Medical
14.8. Gore Medical
14.9. Getz Healthcare
14.10. avascular S.L.U
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

Becton, Dickinson and Company, 4. Key Developments, B. Braun Interventional Systems Inc, Getinge, Insrtumed Surgical, Inc, Boston Scientific Corporation, Biotronik, Mermaid Medical, Gore Medical, Getz Healthcare, avascular S.L.U

표 목록 (Tables)

List of Tables

Table 1 Global Covered Stents Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Covered Stents Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Covered Stents Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Covered Stents Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Covered Stents Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Covered Stents Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Covered Stents Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 10 Global Covered Stents Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Covered Stents Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Covered Stents Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Covered Stents Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 18 North America Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Covered Stents Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 23 South America Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Covered Stents Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 28 Europe Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Covered Stents Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Covered Stents Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Covered Stents Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Covered Stents Market Value, By Material Type, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Covered Stents Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Covered Stents Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Becton, Dickinson and Company: Overview

Table 41 Becton, Dickinson and Company: Product Portfolio

Table 42 Becton, Dickinson and Company: Key Developments

Table 43 B. Braun Interventional Systems Inc: Overview

Table 44 B. Braun Interventional Systems Inc: Product Portfolio

Table 45 B. Braun Interventional Systems Inc: Key Developments

Table 46 Getinge: Overview

Table 47 Getinge: Product Portfolio

Table 48 Getinge: Key Developments

Table 49 Insrtumed Surgical, Inc: Overview

Table 50 Insrtumed Surgical, Inc: Product Portfolio

Table 51 Insrtumed Surgical, Inc: Key Developments

Table 52 Boston Scientific Corporation: Overview

Table 53 Boston Scientific Corporation: Product Portfolio

Table 54 Boston Scientific Corporation: Key Developments

Table 55 Biotronik: Overview

Table 56 Biotronik: Product Portfolio

Table 57 Biotronik: Key Developments

Table 58 Mermaid Medical: Overview

Table 59 Mermaid Medical: Product Portfolio

Table 60 Mermaid Medical: Key Developments

Table 61 Gore Medical: Overview

Table 62 Gore Medical: Product Portfolio

Table 63 Gore Medical: Key Developments

Table 64 Getz Healthcare: Overview

Table 65 Getz Healthcare: Product Portfolio

Table 66 Getz Healthcare: Key Developments

Table 67 iVascular S.L.U: Overview

Table 68 iVascular S.L.U: Product Portfolio

Table 69 iVascular S.L.U: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 2 Global Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 4 Global Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Covered Stents Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Covered Stents Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Balloon Expandable Covered Stents Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 9 Bare Metal Covered Stents Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 10 Drug-Eluting Covered Stents Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 11 Bioabsorbable Covered Stents Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 12 Global Covered Stents Market Y-o-Y Growth, By Material Type, 2022-2030 (%)

Figure 13 ePTFE (Expanded Polytetrafluoroethylene) Covered Stents Material Type in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 14 Polyurethane Material Type in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 15 Polyester Covered Stents Material Type in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 16 Global Covered Stents Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 17 Peripheral Vascular Aneurysms Application in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 18 Coarctation of the Aorta Application in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 19 Atherosclerotic Diseases Application in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 20 Coronary Artery Perforations Application in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 21 Global Covered Stents Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 22 Hospitals End-User in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 23 Ambulatory Surgical Centers (ASCs) End-User in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 24 Cardiac Speciality Clinics End-User in Global Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 25 Global Covered Stents Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 26 North America Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 27 Asia-Pacific Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 28 Europe Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 29 South America Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 30 Middle East and Africa Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 31 North America Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 32 North America Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 33 North America Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 34 North America Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 35 North America Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 36 North America Covered Stents Market Share, By Country, 2022 & 2030 (%)

Figure 37 South America Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 38 South America Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 39 South America Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 40 South America Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 41 South America Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 42 South America Covered Stents Market Share, By Country, 2022 & 2030 (%)

Figure 43 Europe Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 44 Europe Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 45 Europe Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 46 Europe Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 47 Europe Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 48 Europe Covered Stents Market Share, By Country, 2022 & 2030 (%)

Figure 49 Asia-Pacific Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 50 Asia-Pacific Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 51 Asia-Pacific Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 52 Asia-Pacific Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 53 Asia-Pacific Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 54 Asia-Pacific Covered Stents Market Share, By Country, 2022 & 2030 (%)

Figure 55 Middle East & Africa Covered Stents Market Value, 2021-2030 (US$ Million)

Figure 56 Middle East & Africa Covered Stents Market Share, By Product Type, 2022 & 2030 (%)

Figure 57 Middle East & Africa Covered Stents Market Share, By Material Type, 2022 & 2030 (%)

Figure 58 Middle East & Africa Covered Stents Market Share, By Application, 2022 & 2030 (%)

Figure 59 Middle East & Africa Covered Stents Market Share, By End-User, 2022 & 2030 (%)

Figure 60 Becton, Dickinson and Company: Financials

Figure 61 B. Braun Interventional Systems Inc: Financials

Figure 62 Getinge: Financials

Figure 63 Insrtumed Surgical, Inc: Financials

Figure 64 Boston Scientific Corporation: Financials

Figure 65 Biotronik: Financials

Figure 66 Mermaid Medical: Financials

Figure 67 Gore Medical: Financials

Figure 68 Getz Healthcare: Financials

Figure 69 iVascular S.L.U: Financials

글로벌 스텐트 시장 – 2023-2030

Global Covered Stents Market -2023-2030